Imeik Technology Development Co Ltd is engaged in Research and development, production and sales of biomedical materials and biopharmaceuticals.
2004
n/a
LTM Revenue $434M
LTM EBITDA $324M
$7.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Imeik Technology Development has a last 12-month revenue of $434M and a last 12-month EBITDA of $324M.
In the most recent fiscal year, Imeik Technology Development achieved revenue of $417M and an EBITDA of $321M.
Imeik Technology Development expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Imeik Technology Development valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $395M | $417M | XXX | XXX | XXX |
Gross Profit | $253M | $376M | XXX | XXX | XXX |
Gross Margin | 64% | 90% | XXX | XXX | XXX |
EBITDA | $303M | $321M | XXX | XXX | XXX |
EBITDA Margin | 77% | 77% | XXX | XXX | XXX |
Net Profit | $174M | $256M | XXX | XXX | XXX |
Net Margin | 44% | 61% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Imeik Technology Development's stock price is CNY 184 (or $25).
Imeik Technology Development has current market cap of CNY 55.6B (or $7.7B), and EV of CNY 51.3B (or $7.1B).
See Imeik Technology Development trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$7.1B | $7.7B | XXX | XXX | XXX | XXX | $0.94 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Imeik Technology Development has market cap of $7.7B and EV of $7.1B.
Imeik Technology Development's trades at 16.3x LTM EV/Revenue multiple, and 21.8x LTM EBITDA.
Analysts estimate Imeik Technology Development's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Imeik Technology Development and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $7.1B | XXX | XXX | XXX |
EV/Revenue | 16.9x | XXX | XXX | XXX |
EV/EBITDA | 22.0x | XXX | XXX | XXX |
P/E | 28.4x | XXX | XXX | XXX |
P/E/Growth | 2.1x | XXX | XXX | XXX |
EV/FCF | 30.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpImeik Technology Development's NTM/LTM revenue growth is 13%
Imeik Technology Development's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Imeik Technology Development's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Imeik Technology Development's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Imeik Technology Development and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 5% | XXX | XXX | XXX | XXX |
EBITDA Margin | 77% | XXX | XXX | XXX | XXX |
EBITDA Growth | 6% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 90% | XXX | XXX | XXX | XXX |
Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
Opex per Employee | n/a | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 10% | XXX | XXX | XXX | XXX |
Opex to Revenue | 23% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Imeik Technology Development acquired XXX companies to date.
Last acquisition by Imeik Technology Development was XXXXXXXX, XXXXX XXXXX XXXXXX . Imeik Technology Development acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Imeik Technology Development founded? | Imeik Technology Development was founded in 2004. |
Where is Imeik Technology Development headquartered? | Imeik Technology Development is headquartered in China. |
Is Imeik Technology Development publicy listed? | Yes, Imeik Technology Development is a public company listed on SHE. |
What is the stock symbol of Imeik Technology Development? | Imeik Technology Development trades under 300896 ticker. |
When did Imeik Technology Development go public? | Imeik Technology Development went public in 2020. |
Who are competitors of Imeik Technology Development? | Similar companies to Imeik Technology Development include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
What is the current market cap of Imeik Technology Development? | Imeik Technology Development's current market cap is $7.7B |
What is the current revenue of Imeik Technology Development? | Imeik Technology Development's last 12-month revenue is $434M. |
What is the current EBITDA of Imeik Technology Development? | Imeik Technology Development's last 12-month EBITDA is $324M. |
What is the current EV/Revenue multiple of Imeik Technology Development? | Current revenue multiple of Imeik Technology Development is 16.3x. |
What is the current EV/EBITDA multiple of Imeik Technology Development? | Current EBITDA multiple of Imeik Technology Development is 21.8x. |
What is the current revenue growth of Imeik Technology Development? | Imeik Technology Development revenue growth between 2023 and 2024 was 5%. |
Is Imeik Technology Development profitable? | Yes, Imeik Technology Development is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.